Market cap
$6.572 B
$100.95 -0.12%
Close of 7 Aug 2026
Revenue
$1.54B
#1283 by revenue
Earnings
$233.6M
#940 by earnings
Shares outstanding
65,272,369
Latest filing cover page
P/E ratio
28.1
Cap ÷ net income
Biotechnology: In Vitro & In Vivo Diagnostic Substances — ranked by market cap
All 19 →Where these numbers come from
Share counts and financials for Lantheus are taken from its own SEC filings via EDGAR — public record, not an estimate. Market cap is shares outstanding multiplied by the latest close. Last updated 9 Aug 2026. Read the methodology.